BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15010143)

  • 1. Determining the relative physical stability of anhydrous and hydrous crystal forms of GW2016.
    Sacchetti M
    Int J Pharm; 2004 Apr; 273(1-2):195-202. PubMed ID: 15010143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility and stability of anhydrate/hydrate in solvent mixtures.
    Qu H; Louhi-Kultanen M; Kallas J
    Int J Pharm; 2006 Sep; 321(1-2):101-7. PubMed ID: 16784825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
    Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
    Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of phase boundaries in anhydrate/hydrate systems.
    Krzyzaniak JF; Williams GR; Ni N
    J Pharm Sci; 2007 May; 96(5):1270-81. PubMed ID: 17455300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid conversion of API hydrates to anhydrous forms in aqueous media.
    Petrova RI; Peresypkin A; Mortko CJ; McKeown AE; Lee J; Williams JM
    J Pharm Sci; 2009 Nov; 98(11):4111-8. PubMed ID: 19384923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of moisture on the physical stability of polymorphic olanzapine.
    Paisana MC; Wahl MA; Pinto JF
    Int J Pharm; 2016 Jul; 509(1-2):135-148. PubMed ID: 27234701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.
    Karki S; Friscić T; Jones W; Motherwell WD
    Mol Pharm; 2007; 4(3):347-54. PubMed ID: 17497885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and Characterization of Hydrate Forms of T-3256336, a Novel Inhibitor of Apoptosis (IAP) Protein Antagonist.
    Takeuchi S; Kojima T; Hashimoto K; Saito B; Sumi H; Ishikawa T; Ikeda Y
    Chem Pharm Bull (Tokyo); 2015; 63(11):858-65. PubMed ID: 26521850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical stability enhancement of theophylline via cocrystallization.
    Trask AV; Motherwell WD; Jones W
    Int J Pharm; 2006 Aug; 320(1-2):114-23. PubMed ID: 16769188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RH-temperature stability diagram of α- and β-anhydrous and monohydrate lactose crystalline forms.
    Allan MC; Grush E; Mauer LJ
    Food Res Int; 2020 Jan; 127():108717. PubMed ID: 31882085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydration and dehydration kinetics of xylazine hydrochloride.
    Bērziņs A; Actiņs A; Kreismanis JP
    Pharm Dev Technol; 2009; 14(4):388-99. PubMed ID: 19630697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilengitide--exceptional pseudopolymorphism of a cyclic pentapeptide.
    Saal C; Lange M; Kuehn C; Untenecker H; Jonczyk A; Petersen S; Scholz G; Buback V; Dotzauer M; Bauer H; Foerster J; Schumacher J; Metz A; Schmidt M; Seemann K
    Eur J Pharm Sci; 2015 Apr; 71():1-11. PubMed ID: 25681628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RH-Temperature Stability Diagram of the Dihydrate, β-Anhydrate, and α-Anhydrate Forms of Crystalline Trehalose.
    Allan M; Chamberlain MC; Mauer LJ
    J Food Sci; 2019 Jun; 84(6):1465-1476. PubMed ID: 31042816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pulverization on hydration kinetic behaviors of creatine anhydrate powders.
    Sakata Y; Shiraishi S; Otsuka M
    Colloids Surf B Biointerfaces; 2004 Dec; 39(4):187-93. PubMed ID: 15555902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moisture sorption, compressibility and caking of lactose polymorphs.
    Listiohadi Y; Hourigan JA; Sleigh RW; Steele RJ
    Int J Pharm; 2008 Jul; 359(1-2):123-34. PubMed ID: 18485633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing pseudopolymorphic transitions in pharmaceutical solids using Raman spectroscopy: hydration and dehydration of theophylline.
    Amado AM; Nolasco MM; Ribeiro-Claro PJ
    J Pharm Sci; 2007 May; 96(5):1366-79. PubMed ID: 17455358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocrystal dissociation in the presence of water: a general approach for identifying stable cocrystal forms.
    Eddleston MD; Madusanka N; Jones W
    J Pharm Sci; 2014 Sep; 103(9):2865-2870. PubMed ID: 24824298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.